Cargando…

The association between smoking and the prevalence of metabolic syndrome and its components in patients with psoriasis aged 30 to 49 years

INTRODUCTION: Cigarette smoking may exacerbate and cause psoriasis. Moreover, smokers are more likely to develop insulin resistance and metabolic syndrome (MS). AIM: To assess the prevalence of MS and its components in patients with psoriasis, who smoke, compared with the general Polish population o...

Descripción completa

Detalles Bibliográficos
Autores principales: Owczarczyk-Saczonek, Agnieszka B., Nowicki, Roman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4692818/
https://www.ncbi.nlm.nih.gov/pubmed/26759540
http://dx.doi.org/10.5114/pdia.2015.54743
_version_ 1782407292955656192
author Owczarczyk-Saczonek, Agnieszka B.
Nowicki, Roman
author_facet Owczarczyk-Saczonek, Agnieszka B.
Nowicki, Roman
author_sort Owczarczyk-Saczonek, Agnieszka B.
collection PubMed
description INTRODUCTION: Cigarette smoking may exacerbate and cause psoriasis. Moreover, smokers are more likely to develop insulin resistance and metabolic syndrome (MS). AIM: To assess the prevalence of MS and its components in patients with psoriasis, who smoke, compared with the general Polish population of smokers. MATERIAL AND METHODS: We studied 29 patients with psoriasis (female = 9, male = 20), smokers, aged 30 to 49 years. Metabolic syndrome and its components were assessed using the IDF definition and compared to the results obtained in a representative sample of adult Poles in the NATPOL 2011 study in the same age group, including smokers. RESULTS: The results have shown that patients with psoriasis are more likely to be smokers (p < 0.0034) and the frequency of smoking in men is approximately 25% higher than in males of the control group (p < 0.0017). The prevalence of MS in patients with psoriasis who smoke was 27.58% and in the control group 25.2% (p > 0.05). Mean body mass index was 26.07 kg/m(2) in psoriasis patients and 25.59 kg/m(2) in the control group (p > 0.05), and abdominal obesity was 88.82 cm and 90.02 cm (p > 0.05), respectively. There were no differences in hypertension (34.48% vs. 31.6%, p < 0.05) and mean HOMA-IR (1.80 vs. 1.77, p > 0.05). In lipid parameters, the differences were observed only in women with psoriasis – higher levels of HDL, triglycerides and ApoB/ApoA1 index compared with addicted women in the control group. CONCLUSIONS: Men with psoriasis are more often addicted to smoking. Women with psoriasis who smoke have often disturbances of the lipid profile.
format Online
Article
Text
id pubmed-4692818
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-46928182016-01-12 The association between smoking and the prevalence of metabolic syndrome and its components in patients with psoriasis aged 30 to 49 years Owczarczyk-Saczonek, Agnieszka B. Nowicki, Roman Postepy Dermatol Alergol Original Paper INTRODUCTION: Cigarette smoking may exacerbate and cause psoriasis. Moreover, smokers are more likely to develop insulin resistance and metabolic syndrome (MS). AIM: To assess the prevalence of MS and its components in patients with psoriasis, who smoke, compared with the general Polish population of smokers. MATERIAL AND METHODS: We studied 29 patients with psoriasis (female = 9, male = 20), smokers, aged 30 to 49 years. Metabolic syndrome and its components were assessed using the IDF definition and compared to the results obtained in a representative sample of adult Poles in the NATPOL 2011 study in the same age group, including smokers. RESULTS: The results have shown that patients with psoriasis are more likely to be smokers (p < 0.0034) and the frequency of smoking in men is approximately 25% higher than in males of the control group (p < 0.0017). The prevalence of MS in patients with psoriasis who smoke was 27.58% and in the control group 25.2% (p > 0.05). Mean body mass index was 26.07 kg/m(2) in psoriasis patients and 25.59 kg/m(2) in the control group (p > 0.05), and abdominal obesity was 88.82 cm and 90.02 cm (p > 0.05), respectively. There were no differences in hypertension (34.48% vs. 31.6%, p < 0.05) and mean HOMA-IR (1.80 vs. 1.77, p > 0.05). In lipid parameters, the differences were observed only in women with psoriasis – higher levels of HDL, triglycerides and ApoB/ApoA1 index compared with addicted women in the control group. CONCLUSIONS: Men with psoriasis are more often addicted to smoking. Women with psoriasis who smoke have often disturbances of the lipid profile. Termedia Publishing House 2015-10-29 2015-10 /pmc/articles/PMC4692818/ /pubmed/26759540 http://dx.doi.org/10.5114/pdia.2015.54743 Text en Copyright © 2015 Termedia http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License, permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Paper
Owczarczyk-Saczonek, Agnieszka B.
Nowicki, Roman
The association between smoking and the prevalence of metabolic syndrome and its components in patients with psoriasis aged 30 to 49 years
title The association between smoking and the prevalence of metabolic syndrome and its components in patients with psoriasis aged 30 to 49 years
title_full The association between smoking and the prevalence of metabolic syndrome and its components in patients with psoriasis aged 30 to 49 years
title_fullStr The association between smoking and the prevalence of metabolic syndrome and its components in patients with psoriasis aged 30 to 49 years
title_full_unstemmed The association between smoking and the prevalence of metabolic syndrome and its components in patients with psoriasis aged 30 to 49 years
title_short The association between smoking and the prevalence of metabolic syndrome and its components in patients with psoriasis aged 30 to 49 years
title_sort association between smoking and the prevalence of metabolic syndrome and its components in patients with psoriasis aged 30 to 49 years
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4692818/
https://www.ncbi.nlm.nih.gov/pubmed/26759540
http://dx.doi.org/10.5114/pdia.2015.54743
work_keys_str_mv AT owczarczyksaczonekagnieszkab theassociationbetweensmokingandtheprevalenceofmetabolicsyndromeanditscomponentsinpatientswithpsoriasisaged30to49years
AT nowickiroman theassociationbetweensmokingandtheprevalenceofmetabolicsyndromeanditscomponentsinpatientswithpsoriasisaged30to49years
AT owczarczyksaczonekagnieszkab associationbetweensmokingandtheprevalenceofmetabolicsyndromeanditscomponentsinpatientswithpsoriasisaged30to49years
AT nowickiroman associationbetweensmokingandtheprevalenceofmetabolicsyndromeanditscomponentsinpatientswithpsoriasisaged30to49years